Antiarrhythmic drug therapy of atrial fibrillation-Reference-Cited by-同舟云学术

Antiarrhythmic drug therapy of atrial fibrillation

Published:2004-02 Issue:1 Volume:22 Page:21-34
ISSN:0733-8651
Container-title:Cardiology Clinics
language:en
Short-container-title:Cardiology Clinics

Author:

VerNooy Robert A,Mounsey J.Paul

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Cardiology and Cardiovascular Medicine,General Medicine

Reference109 articles.

1. A comparison of rate control and rhythm control in patients with atrial fibrillation. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) investigators;AFFIRM Investigators;N Engl J Med,2002

2. Subgroups of class 1 antiarrhythmic drugs;Vaughan Williams;Eur Heart J,1984

3. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multi-center Investigators Group;Dorian;Am J Cardiol,1996

4. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation;UK Propafenone PSVT Study Group;Circulation,1995

5. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias;Hohnloser;Am J Cardiol,1992

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tachyarrhythmien;Das ICU-Buch;2017

2. Managing Arrhythmias in the Intensive Care Unit;Critical Care Clinics;2014-07

3. A Formula for the Stratified Selection of Patients with Paroxysmal Atrial Fibrillation in the Emergency Setting: A Retrospective Pilot Study;The Journal of Emergency Medicine;2011-04

4. Atrial Fibrillation with a Focus on Oral Antiarrhythmic Therapy;Current Drug Therapy;2011-02-01

5. Alterations of atrial Ca2+ handling as cause and consequence of atrial fibrillation;Cardiovascular Research;2010-12-15